BioAge Labs (BIOA) Other financing activities (2023 - 2026)

BioAge Labs has disclosed Other financing activities across 4 years of filings, most recently posting $716000.0 for Q1 2026.

• Other financing activities for Q1 2026 came in at $716000.0, changed N/A year-over-year; the trailing twelve-month figure through Mar 2026 was $716000.0 (up 1690.0% YoY), and the FY2024 annual result was $542000.0, up 3088.24% from the prior year.
• Other financing activities came in at $716000.0 for Q1 2026 at BioAge Labs, up from -$44000.0 in the prior quarter.
• In the past five years, Other financing activities ranged from a high of $716000.0 in Q1 2026 to a low of -$542000.0 in Q3 2024.
• The 4-year median for Other financing activities is $42000.0 (2024), against an average of $153625.0.
• Across the five-year window, Other financing activities surged 1968.97% in 2024 and tumbled 108.12% in 2025, its largest moves.
• BioAge Labs' Other financing activities stood at -$29000.0 in 2023, then soared by 1968.97% to $542000.0 in 2024, then tumbled by 108.12% to -$44000.0 in 2025, then soared by 1727.27% to $716000.0 in 2026.
• The last three Other financing activities figures came in at $716000.0 (Q1 2026), -$44000.0 (Q4 2025), and $44000.0 (Q3 2025), per Business Quant data.